Inhibition of DNA synthesis by downregulation of cyclin A but not Skp 2 overexpression in human hepatocellular carcinoma cells

Cancer Lett. 1999 May 3;139(1):1-6. doi: 10.1016/s0304-3835(98)00352-8.

Abstract

Cyclin A is an S and G2/M phase regulatory protein and associates with Skp 2 in many transformed cells. Our previous results showed that 12 (39%) and 17 (55%) out of 31 hepatocellular carcinoma (HCC) patients exhibited higher protein expression levels of cyclin A and Skp 2, respectively, in their tumorous compared to non-tumorous tissues. In the present study, we used Western blot analysis to show that 3 out of 6 HCC cell lines, HA59T, HA22T and HCC36, exhibited overexpression of cyclin A, among which the HCC36 cell line also expressed a higher Skp 2 protein level. Moreover, we used the antisense oligonucleotide phosphorothioates to down regulate the overexpression of cyclin A and Skp 2 proteins to determine whether or not these two proteins are involved in the mitogenesis of HCC36 cells. After treatment with antisense oligonucleotide phosphorothioates, the gene product of cyclin A or Skp 2 was suppressed dose-dependently as revealed by Western blot analyses. By [3H]thymidine incorporation assay, we found that downregulation of cyclin A but not Skp 2 overexpression could inhibit the DNA synthesis ability of HCC36 cells, suggesting that abnormal Skp 2 expression is not directly correlated with the HCC proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / metabolism*
  • Cell Cycle Proteins / metabolism*
  • Cyclin A / metabolism*
  • DNA, Neoplasm / biosynthesis*
  • Dose-Response Relationship, Drug
  • Down-Regulation*
  • Humans
  • Oligonucleotides, Antisense
  • S-Phase Kinase-Associated Proteins
  • Tumor Cells, Cultured

Substances

  • Cell Cycle Proteins
  • Cyclin A
  • DNA, Neoplasm
  • Oligonucleotides, Antisense
  • S-Phase Kinase-Associated Proteins